JENRIN DISCOVERY INC has a total of 17 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CT NAC INVESTIGACIONES ONCOLOGICAS CNIO, GLUCOX BIOTECH AB and CHENG JINGCAI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | Israel | 2 | |
#5 | Australia | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hungary | 1 | |
#8 | India | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Mcelroy John | 8 |
#2 | Chorvat Robert | 8 |
#3 | Chorvat Robert J | 5 |
#4 | Mcelroy John F | 3 |
#5 | Mcelroy John Francis | 3 |
#6 | Chorvat Robert John | 1 |
#7 | Rajagopalan Parthasarathi | 1 |
#8 | John Mcelroy | 1 |
#9 | Robert Chorvat | 1 |
Publication | Filing date | Title |
---|---|---|
US2009118345A1 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |